Good find sholtz.
Well-spoken pitch for the company, but he is inaccurate, as they are NOT fully funded to see out the end of the OA trial.
Others on this site have spoken about their cash situation, but the company themselves have never detailed what these trials will cost or what they have modelled for.
Costs will double from here (once they actually start), so if they have about $60m in the bank now (was $72m at end of March) and cost go from current $10m quarterly run rate to $20m, I suspect everyone can do the math.
A capital raise will have to be done this year, as come the end of fourth quarter, they will have about two quarters of cash left.
Many on here are believing a deal from MPS is just around the corner, which is a reasonable belief when you listen to this Company Chairperson, I hope for current shareholders that it is true.
Good find sholtz. Well-spoken pitch for the company, but he is...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $101.4M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.3¢ | 28.0¢ | $57.32K | 198.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12454 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 4443 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |